Alpha-Synuclein PET/CT in Various α-Syn-Related Disease
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
To evaluate the potential usefulness of 18F-FIAT-2, 18F-C05-05, 18F-SPAL-T-06 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various α-Syn-related disease patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: t
View:
• (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated PD (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled α-Syn PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.
Locations
Other Locations
China
Tianjin Medical University General Hospital
RECRUITING
Tianjin
Contact Information
Primary
Ying Wang, MD
macrossplusvoices@163.com
+8618702292537
Backup
Li Cai, MD
xcl242004@126.com
+862260362190
Time Frame
Start Date: 2025-04-01
Estimated Completion Date: 2028-04-01
Participants
Target number of participants: 500
Treatments
Single Group Assignment
Each subject receive a single intravenous injection of 18F-FIAT-2, 18F-C05-05, 18F-SPAL-T-06 and undergo PET/CT or MRI imaging within the specificed time.
Related Therapeutic Areas
Sponsors
Leads: Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital